Am J Transplant, Volume 20, Suppl 3 Archives - Page 105 of 223 - ATC Abstracts

2020 American Transplant Congress
Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression During the First Year Post-Transplant (<1yr Tx) Increases Risk for CMV Infection Through Inhibition of Anti-CMV Humoral Immunity
B. Shin, N. Ammerman, S. Sethi, A. Vo, S. C. Jordan, M. Toyoda
Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: We have shown a higer CMV infection rate in kidney Tx patients (KTx Pts) who were converted to BLT 1yr post-Tx. Viral infections are…
2020 American Transplant Congress
Lowering Meld, Diminishing Length of Stay, and Increasing Liver Transplant Numbers Comes Through the Generosity of Others: Declined HCV-NAT Offers Subsequently Transplanted Have Excellent Outcomes
R. Gilroy, S. Sell, J. Krong, A. Gagnon, I. Zendejas, S. Fujita, M. Rodriguez, D. Alonso
Transplant Services, Intermountain Healthcare, Murray, UT
*Purpose: There is variability between programs in the acceptance of organ offers. This paper examines offer, acceptance and program performance with HCV NAT positive donor…
2020 American Transplant Congress
Transplant Outcomes, Risk Factors, and Regional Variation in Selection of Morbidly Obese Liver Transplant Candidates in the US
T. Lian¹, N. Kaur², J. Emamaullee², M. Lo³, P. Ender⁴, J. Kahn⁵, L. Sher²
¹Keck School of Medicine at USC, Los Angeles, CA, ²Department of Surgery, Keck School of Medicine at USC, Los Angeles, CA, ³Department of Preventative Medicine, Keck School of Medicine at USC, Los Angeles, CA, ⁴Statistical Consulting Group, University of California Los Angeles, Los Angeles, CA, ⁵Department of Medicine, Keck School of Medicine at USC, Los Angeles, CA
*Purpose: Body Mass Index (BMI) limits for liver transplant (LT) candidacy are controversial. We evaluated waitlist and post-LT outcomes, prognostic factors, and regional patterns of…
2020 American Transplant Congress
Hypernatremia Predicts Waitlist Death and Deterioration, but Not Post-Transplant Outcomes in Pediatric Liver Transplant Candidates
L. Thalji¹, N. Thalji², S. Ibrahim³, J. Heimbach², P. Kamath⁴, D. Haile¹, D. Kor¹
¹Anesthesiology, Mayo Clinic, Rochester, MN, ²Surgery, Mayo Clinic, Rochester, MN, ³Pediatric Gastroenterology, Mayo Clinic, Rochester, MN, ⁴Gastroenterology, Mayo Clinic, Rochester, MN
*Purpose: Pre-transplant hypernatremia has been shown to predict post-transplant mortality in adult liver transplant (LT) recipients. The effects of hypernatremia in children, however, remain unexplored.…
2020 American Transplant Congress
Rates of Urinary Tract Infections in Kidney Transplant Patients Using Trimethoprim/Sulfamethoxazole versus Alternative Agents for Pneumocystis Jiroveci Prophylaxis
L. C. Laird, R. M. Nygaard, T. L. Anderson-Haag, A. M. Spenningsby, P. A. Stahler
Hennepin Healthcare, Minneapolis, MN
*Purpose: Trimethoprim/sulfamethoxazole (TMP/SMX) is used in kidney transplant patients for prophylaxis against Pneumocystis jiroveci pneumonia (PJP) and has demonstrated a decrease in the incidence of…
2020 American Transplant Congress
Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction
R. Hod Dvorai¹, R. Lee², P. Muluhngwi², M. Raijmakers³, A. Shetty², A. Tambur², M. Ison²
¹Department of Pathology, SUNY Upstate Medical University, Syracuse, NY, ²Northwestern University, Chicago, IL, ³University of Santiago, Santiago, Chile
*Purpose: To evaluate development of de novo donor specific antibodies (dnDSA) in Renal Transplant Recipients (RTR) with immunosuppression (IS) modulation due to BK viremia (BKV)…
2020 American Transplant Congress
Racial Disparities in Long-Term Outcomes in Kidney Transplantation from Elderly Donors in United States
S. Shah, B. Abu Jawdeh, S. Bumb, T. Kaur, M. Anand, A. Govil, R. Jain
University of Cincinnati, Cincinnati, OH
*Purpose: Kidney transplantation offers survival benefit and improved quality of life in end-stage renal disease patients. Because the waiting list continues to grow, there has…
2020 American Transplant Congress
Accomplishment of Ischemia-Free Kidney Transplantation Using Normothermic Machine Perfusion
G. Chen, X. He, C. Wang, X. Yuan, M. Han, Z. Guo
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
*Purpose: Ischemia-reperfusion injury (IRI) has been considered an inevitable event in organ transplantation since the first successful kidney transplant was performed in 1954. To avoid…
2020 American Transplant Congress
In-Depth Assessment of Ischemia/Reperfusion Injury in a Murine Model of Hindlimb Transplantation
F. Messner¹, K. Kadono², Y. Guo¹, B. Oh¹, J. Kupiec-Weglinski², G. Brandacher¹
¹Department of Plastic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, ²Department of Surgery, Division of Liver and Pancreas Transplantation, University of California, Los Angeles, Los Angeles, CA
*Purpose: Static cold storage (SCS) still represents the gold standard for organ and tissue preservation in transplantation. Ischemia/reperfusion injury (IRI) that occurs due to the…
2020 American Transplant Congress
Utilization of High Terminal Creatinine Kidney Donors for Simultaneous Kidney and Pancreas Transplantation
A. Montal, J. Torabi, N. Muhdi, J. Melvin, Y. Miura, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, E. Akalin, S. Greenstein, J. P. Rocca, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: The use of kidneys with high terminal creatinine has been demonstrated in renal transplantation with excellent outcomes. Here we explore the use of high…